Jill Wechsler

White House backs big boost in funding for research, public health.

An updated version of legislation to modernize clinical research policies and FDA expedited approval pathways is circulating on Capitol Hill in anticipation of gaining approval in the coming year.

Separate pushes for vaccine equity, legislation to lower drug costs.

Officials struggle to maintain the credibility of its drug regulatory process after accusations of intentionally delaying COVID-19 vaccine testing for political reasons.